COMMUNIQUÉS West-GlobeNewswire

Avicanna Announces Changes to its Board of Directors
06/04/2026
TORONTO, April 06, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and [...]
Immuneering to Present at the 25th Annual Needham Virtual Healthcare Conference
06/04/2026
NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced that Ben [...]
Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy
06/04/2026
EPO Greenlights Claims Covering Preventative use of therapy targeting 5-HT4 Pathway and Expands Silo Pharma IP Portfolio SARASOTA, FL, April 06, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “ [...]
Nanox to Report Fourth Quarter 2025 Financial Results on April 20, 2026
06/04/2026
PETACH TIKVA, Israel, April 06, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial [...]
Metabo Drops Claims Evaluated: Recent Investigation Into MetaboDrops Official Website Announcement
06/04/2026
A 2026 informational overview of Metabo Drops coffee metabolism drop marketing claims, proprietary blend label disclosures, ingredient dosage research context, pricing structure, 60-day guarantee terms, and what men and [...]
Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development
06/04/2026
Includes novel proteomic and genomic approaches to oncology therapeutic selection, response monitoring, and Molecular Residual Disease (MRD) testing LOUISVILLE, Colo., April 06, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. ( [...]
DIBS AI Unveils Version 9.0 Platform Suite to Streamline Orthodontic Workflows
06/04/2026
Three AI-driven platforms improve efficiency, predictability, and turnaround times—delivered at $165 per case AMERICAN FORK, Utah, April 06, 2026 (GLOBE NEWSWIRE) -- DIBS AI ® , a division of OrthoSelect, announces the [...]
Stereotaxis Announces FDA Clearance and Launch of Synchrony System
06/04/2026
ST. LOUIS, April 06, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has received U.S. Food [...]
Stablecoin Development Corporation Begins Trading on NYSE American Under Ticker “SDEV”
06/04/2026
Company Announces Completion of Corporate Name Change and Provides Updated SKY Holdings and Staking Metrics EMERYVILLE, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Stablecoin Development Corporation (NYSE American: SDEV [...]
Flare Therapeutics Announces Three Upcoming Poster Presentations at AACR Annual Meeting 2026
06/04/2026
CAMBRIDGE, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other [...]
Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its Novel ADC Payload Targeting RNA Splicing
06/04/2026
Strategic Partnership Enables Akari to Accelerate IND Filing By Late 2026 TAMPA, Fla. and LONDON, April 06, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing [...]
Scienture Provides Annual Shareholder Update, Outlining Significant Progress and Strategic Priorities for the Year Ahead
06/04/2026
COMMACK, NY, April 06, 2026 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (“Scienture”) a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to [...]
Oncolytics Biotech® Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for Pelareorep in Anal Cancer
06/04/2026
SAN DIEGO, April 06, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, an investigational, systemically [...]
Curanex Highlights Patient Case Study Supporting Potential of Phyto-N in Cancer Cachexia and Advanced Cancer Supportive Care
06/04/2026
Case involving senior dosimetrist at a premier cancer hospital in the Northeast suggests potential relevance of Phyto-N in one of oncology’s most serious and underserved supportive-care markets Jericho, New York, April [...]
Egg Medical présente EggNest™ Complete Flex : une protection sans tablier, sans travaux, sans interruption de service ni perturbation
06/04/2026
MINNEAPOLIS, 06 avr. 2026 (GLOBE NEWSWIRE) -- Egg Medical annonce le lancement d’EggNest™ Complete Flex, une avancée révolutionnaire en matière de protection contre les radiations qui permet aux cliniciens de travailler [...]
OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data
06/04/2026
MINNEAPOLIS, April 06, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory decision-grade, AI-Driven Real-World Data (RWD [...]
Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure
06/04/2026
Jilin, China, April 06, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing [...]
Egg Medical Launches EggNest™ Complete Flex: Apron-Free Protection Without Construction, Downtime or Disruption
06/04/2026
MINNEAPOLIS, April 06, 2026 (GLOBE NEWSWIRE) -- Egg Medical announces the launch of EggNest™ Complete Flex, a groundbreaking advancement in radiation protection that enables clinicians to safely work apron-free or with [...]
TOMI Environmental Solutions, Inc. Announces Surge in SteraMist Adoption Across Compounding Pharmacy Industry Amid Tightening Regulatory Standards
06/04/2026
SteraMist iHP Expansion into Compounding 503A and 503B Pharmacies FREDERICK, Md., April 06, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and [...]

Pages